Cell Reports
Published April 16, 2019 | 11:00 EDT (News release from University of Toronto)
Glioblastoma is one of the most devastating forms of cancer, with few existing treatment options. It is also a leading cause of cancer-related death in children and young adults. Scientists have reverse engineered brain cancer stem cells gene by gene, uncovering multiple potential targets for this hard-to-treat cancer. This is the first published study to systematically profile a large panel of patient-derived brain tumour cells that have stem cell properties.

Corresponding authors: Peter Dirks, SickKids – peter.dirks@sickkids.ca; Stéphane Angers, University of Toronto – Stephane.Angers@utoronto.ca